First Autonomous Driverless Tractor Greenbot Introduced At AgriTechnica

Nov 19, 2015

Farms.com Team

Information from www.precisionmakers.com

A Dutch company, Conver introduces the first autonomous driverless tractor named Greenbot at the recent Agritechnica tradeshow in Germany. The Greenbot is the first self-propelled machine to be developed especially for all professionals in the green, landscaping, horticulture sector who perform actions which are repeated regularly. These can vary from activities for fruit growing, market gardening, agriculture to the municipal sector. The Greenbot can also be used on golf links to cut lawns and a wide range of jobs can be performed fully unmanned. The Greenbot breaks new ground in every respect. From a technical viewpoint, the machine has been built with the very best materials in accordance with the latest technical insights. The electronics include the best GPS system based on the patented Teach & Playback technology from Probotiq.

Farms.com is waiting on word from the company on when they plan to introduce this technology in North America.

For more information visit http://www.precisionmakers.com

Greenbot - first driverless machine:

Source: precisionmakers

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.